249 related articles for article (PubMed ID: 32050882)
1. [Investigation of Anti-HCV S/CO Value in Detecting Viremia in Patients with Hepatitis C Virus Infection].
Aydın G; Adaleti R; Boz ES; Yücel FM; Özhan HK; Aksaray S
Mikrobiyol Bul; 2020 Jan; 54(1):110-119. PubMed ID: 32050882
[TBL] [Abstract][Full Text] [Related]
2. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
Lopes EP; Gouveia EC; Albuquerque AC; Sette LH; Mello LA; Moreira RC; Coelho MR
J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
[TBL] [Abstract][Full Text] [Related]
3. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
Kusendová K; Gavorník P; Sabaka P; Sviteková K
Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
[TBL] [Abstract][Full Text] [Related]
4. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.
Huang WS; Lu SN; Wang JH; Lee CM; Tung HD; Chen TM; ChangChien CS
Hepatogastroenterology; 2005; 52(63):893-6. PubMed ID: 15966227
[TBL] [Abstract][Full Text] [Related]
5. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Soriano S; Aljama P
Clin Nephrol; 2000 Aug; 54(2):151-6. PubMed ID: 10968693
[TBL] [Abstract][Full Text] [Related]
6. [Investigation of the correlation between anti-HCV levels (S/Co) with HCV-RNA in the diagnosis of hepatitis C virus (HCV) infection].
Şanlıdağ T; Akçalı S; Ecemiş T; Süer K; Erbay Dündar P; Arıkan A; Güvenir M; Güler E
Mikrobiyol Bul; 2016 Jul; 50(3):508-10. PubMed ID: 27525408
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Architect anti-HCV Signal to Cutoff Ratios for Predicting Hepatitis C Viremia Using COBAS AmpliPrep/COBAS TaqMan HCV Quantitative Test.
He Y; Chen Y; Wang Y; Chen X; Huang H; Yu X; He X; Zeng W; Liu M; Huang B; Chen P
Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776744
[TBL] [Abstract][Full Text] [Related]
8. Utilization of Signal-to-Cutoff Ratio of Hepatitis C Virus Antibody Assay in Predicting HCV Viremia among Hemodialysis Patients.
Kao HH; Chen KS; Lin CL; Chang JJ; Lee CH
Nephron; 2015; 130(2):127-33. PubMed ID: 26065912
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the patients with low levels of anti-HCV positivity].
Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].
Benouda A; Boujdiya Z; Ahid S; Abouqal R; Adnaoui M
Pathol Biol (Paris); 2009 Jul; 57(5):368-72. PubMed ID: 18842351
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection.
Kang JG; Jang MK; Kim JH; Jung JH; Park JW; Kim SE; Park SH; Lee MS; Suk KT; Kim DJ; Kim HS
Korean J Intern Med; 2023 May; 38(3):362-371. PubMed ID: 37038262
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of biochemical, hematological, RIBA and PCR assays in predicting viremia in anti-HCV positive patients.
Sirin MC; Cicioglu Aridogan B; Sesli Cetin E; Sirin FB
J Infect Dev Ctries; 2019 Aug; 13(8):736-743. PubMed ID: 32069258
[TBL] [Abstract][Full Text] [Related]
13. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
[TBL] [Abstract][Full Text] [Related]
14. Threshold value of the anti-HCV test in the diagnosis of HCV infection.
Kirişci Ö; Calıskan A
J Infect Dev Ctries; 2019 Oct; 13(10):914-919. PubMed ID: 32084022
[TBL] [Abstract][Full Text] [Related]
15. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
[TBL] [Abstract][Full Text] [Related]
16. Virological features of hepatitis C virus infection in hemodialysis patients.
Silini E; Bono F; Cerino A; Piazza V; Solcia E; Mondelli MU
J Clin Microbiol; 1993 Nov; 31(11):2913-7. PubMed ID: 7505292
[TBL] [Abstract][Full Text] [Related]
17. Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia.
Seo YS; Jung ES; Kim JH; Jung YK; Kim JH; An H; Yim HJ; Yeon JE; Byun KS; Kim CD; Ryu HS; Um SH
Korean J Intern Med; 2009 Dec; 24(4):302-8. PubMed ID: 19949727
[TBL] [Abstract][Full Text] [Related]
18. Improved reflexive testing algorithm for hepatitis C infection using signal-to-cutoff ratios of a hepatitis C virus antibody assay.
Lai KK; Jin M; Yuan S; Larson MF; Dominitz JA; Bankson DD
Clin Chem; 2011 Jul; 57(7):1050-6. PubMed ID: 21566071
[TBL] [Abstract][Full Text] [Related]
19. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey].
Aktaş E; Ogedey ED; Külah C; Beğendik Cömert F
Mikrobiyol Bul; 2010 Oct; 44(4):647-50. PubMed ID: 21063977
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
